Reengineering Ponatinib to Minimize Cardiovascular Toxicity. Hnatiuk AP, Bruyneel AAN, Tailor D, Pandrala M, et al. Cancer Res 2022;82:2777-2791.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hnatiuk AP, Bruyneel AAN, Tailor D, Pandrala M, et al. Reengineering Ponatinib to Minimize Cardiovascular Toxicity. Cancer Res 2022;82:2777-2791.
PMID: 35763671